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Safety in the neonatal and 
infant transport system: 
report on three cases 
with evidence-based 
comments on safety during 
transportation
ABSTRACT
Infant transport has been carried out in Slovenia since 1976. Applying the principles of safe transport was essential to 
avoid unexpected exposure of critically ill infants to unnecessary and adverse events. Besides organizational and technical 
prerequisites for safe transportation, evidence-based clinical knowledge and practical competence are of utmost impor-
tance. Furthermore, the ongoing possibility of consulting other colleagues during transportation, choose the optimal form 
of retrieval of very sick infants, is sometimes needed and preferred. Three different cases are presented here where skilled 
medical teams decided how to transport critically ill infants, and at what risks and costs. All three transports were succe-
ssfully completed with good outcomes despite difficult clinical conditions prior to and during retrieval.
STEFAN GROSEK (  )
University Medical Center Ljubljana 
Surgical Service 
Department of Pediatric Surgery 
and Intensive Therapy 
Medical Faculty, University of Ljubljana
Bohoriceva 20, 1525 Ljubljana, Slovenia
GSM ++ 386 (0)41 684 206
Phone: 386 (0)1 522 48 29
Phone: ++ 386 (0)1 522 33 49






   SIGNA VITAE 2014; 9(1)
Key words: safety, neonatal tran-
sport, pneumothorax, prostaglandin 
infusion, extracorporeal membrane 
oxygenation
Introduction
The safe neonatal transport system in 
Slovenia was started in 1976, two years 
after the new and modern Neonatal and 
Pediatric Intensive Care Unit at the Uni-
versity Medical Centre Ljubljana was 
opened in 1974. (1,2) Those were the 
days when the regionalization of medi-
cal care in specialized tertiary centres 
together with the need for a special-
ized retrieval neonatal transport system 
evolved in Europe, including in Slovenia. 
(3,4) A dedicated team, consisting of a 
pediatric intensivist and a registered 
nurse, together with an ambulance or 
helicopter crew, took responsibility for 
the safe transfer of critically ill infants. 
(2) The primary roles of a referral medi-
cal team are to recognize a critically ill 
infant, to take care of him/her until a 
transport team arrives and to hand-over 
safely and correctly the infant to the 
transport team. A secondary role of the 
referral team is how the transport team 
should make a proper and on-site deci-
sion for the safe retrieval of the critically 
ill infant. A focus on transport safety in 
three different clinical situations with 
evidence based comments will be pre-
sented in the paper below.
Case report 1 
Can we safe ly  accept 
expectant management of 
pneumothorax in the case 
of a critically ill infant who 
has to be transported by 
helicopter or ambulance to 
the intensive care unit? 
A one day old infant, body weight 2460 
grams, length 47 cm, head circumfer-
ence 32 cm, Apgar 10/10 at 1 and 5 
minutes consecutively, of 37 weeks 
gestation, delivered vaginally, devel-
oped respiratory distress syndrome 
(RDS) which necessitated orotracheal 
intubation and artificial hand bagging 
ventilation with pure oxygen. A transport 
team was called to transfer him to the 
Neonatal and Pediatric Intensive Care 
Unit (ICU), University Medical Centre 
Ljubljana. A referral doctor reported 
that after intubation and artificial ventila-
tion, the oxygen saturation of the infant 
improved and was well above 90%. 
His circulatory status was stable, too. 
A neonatal transport team was assem-
bled within 45 minutes after the first call 
was made and needed a further 1 hour 
and 15 minutes to reach the region-
al maternity hospital by ambulance. 
On arrival, the clinical condition of the 
baby at first sight seemed stable, blood 
gases were appropriate, he was pink 
and warm. A clinical diagnosis of RDS 
and hyposurfactosis was suspected. A 
chest radiograph confirmed this. A brief 
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comment by the referral doctor was that 
the lungs were less compliant and did 
not change during the last two hours; 
the compliance of the lungs neither 
improved nor decreased. Prior to trans-
portation, a chest radiograph showed 
a small pneumothorax on the right and 
left side of the lungs (figures 1,2). 
The transport doctor’s dilemma before 
retrieval was whether to insert a thoracic 
tube to remove the air from the pleural 
cavity or to manage it expectantly, i.e., 
to delay the procedure until arriving at 
the ICU and performing it, if still needed. 
The infant was stable, with good capil-
lary refilling, therefore no cardiovascu-
lar compromise was evident, peripheral 
skin saturation was well above 95% on 
80% of oxygen and hyaline membrane 
disease certainly was a predominant 
cause of his problems. Our present 
policy is to wait with artificial surfactant 
instillation until the patient is transferred 
to a safe place, i.e. to the neonatal and 
pediatric ICU, where a dedicated team 
of intensivists are able to solve the clini-
cal problem in a safe environment.
Transportation to the neonatal ICU 
lasted 1 hour and 15 minutes and was 
accomplished without problems either 
during or immediately after transporta-
tion. After checking the vital signs and 
repeating the chest radiograph (figure 
3), which did not show any deterioration 
regarding the air-leak, a decision on how 
to further approach treatment in the ICU, 
besides oxygen and respiratory sup-
port with artificial ventilation, was made. 
While artificial surfactant was warmed up 
at room temperature, a needle puncture 
on the right side of the chest showed a 
positive sign of air bubbles in the syrin-
ge. Therefore, a chest tube was placed 
in the right pleural cavity (figure 4). After 
instilling artificial surfactant, there was 
further improvement in compliance of 
the lungs, decreasing the need for Frac-
tion of Inspired Oxygen (FiO2) (figure 5). 
The small pneumothorax on the left side 
was resolved with no invasive interven-
tion needed. Eventually the right chest 
tube was removed on day 4, the tracheal 
tube on day 7 and the patient was dis-
charged back to the regional maternity 
hospital on day 8.
Figure 1. A chest x-ray with evident signs of hyaline membrane disease and 
pneumothorax on the right and left sides of the chest.
Figure 2. A chest x-ray of the same infant showing no deterioration 40 minutes 
later, before we left the regional maternity hospital.
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important for the transport intensivist, 
because it is well known that firstly, 
pneumothorax is more frequent in the 
neonatal period and that it occurs more 
frequently in transported infants than 
in inborn-infants. (5) However, chest 
tube insertion may cause lung injury, (6) 
phrenic nerve paralysis and many oth-
ers adverse effects. What would hap-
pen if the air-leak further deteriorated 
during transportation? Would it be wise 
to decide for expectancy, i.e., to wait 
instead of adopting an active approach 
with needle aspiration and chest tube 
insertion? An expectant decision relies 
on the following point of view: such an 
infant would never be transported with-
out a chest tube if he had to be trans-
ported by helicopter or if he had severe 
cardiorespiratory problems deteriorat-
ing from the first doctor’s call from the 
maternity hospital. A transport doctor 
has to be aware of accelerations and 
decelerations, influences of decreased 
atmospheric pressure in unpressurized 
helicopters at higher altitudes and pos-
sible increase of air-leak in the chest 
cavity. Furthermore, insertion of a chest 
tube is not possible when the helicopter 
is in the air. If problems related to air-leak 
arise in a car ambulance the transport 
team can just stop the ambulance on 
the hard shoulder of the motorway and 
perform such a procedure. Moreover, 
there were no problems with increasing 
altitude and decreasing atmospheric 
pressure and no acceleration or decel-
eration as can be expected in helicop-
ters. However, car ambulance transfer 
may be problematic for the transport 
of a critically ill infant in regions on the 
Earth’s surface high above sea level, 
i.e.over 2400 meters above sea level, 
when the car ambulance has to pass 
high altitude and then descend to reach 
the hospital which is only 300 to 500 
meters above sea level. 
An interesting retrospective study about 
expectant management of pneumot-
horax in ventilated infants was recently 
published by Ita Litmanovitz et al. which 
confirmed that in some circumstances 
no chest tube insertion is a must. (7) She 
evaluated 136 infants with pneumotho-
rax between 1992 and 2005 who were 
Figure 4. Chest x-ray after insertion of a chest tube in the right hemithorax.
Figure 3. Chest x-ray of the same infant 15 minutes after arrival to the intensi-
ve care unit, University Medical Centre Ljubljana. No differences in 
pneumothoraxes seen in comparison with pictures 1 and 2.
Discussion of Case 1
A lively discussion arose the next day 
during the bedside morning ward 
round regarding the necessity for pre- 
instead of post-transport placement 
of the chest tube. This question was 
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on mechanical ventilation. One quarter 
(26%) were not initially treated with a 
chest tube. Of those initially untreated 
with a chest tube, 14 were treated with 
needle aspiration and 21 with expectant 
treatment. Among these two groups, 
of those who were treated with needle 
aspiration, 43% finally needed chest 
tube insertion, while only 10% in the 
expectant group. They concluded that 
a select group of infants on mechanical 
ventilation can be treated expectantly 
without initial chest tube placement. 
(7) The marked current practice varia-
tion exists among pulmonologists and 
thoracic surgeons treating spontane-
ous pneumothorax and bronchopleural 
fistula. This study showed that more 
than 50% of clinicians used a chest 
tube in mechanically ventilated acute 
respiratory distress syndrome, acute 
respiratory distress syndrome (ARDS) 
related tension pneumothorax in adults, 
while in small spontaneous pneumot-
horax were treated expectantly. (8) In 
blunt occult pneumothorax, Barrios et 
al. found that management without tube 
thoracotomy was adopted in 59 cases 
and was successful in 51 (86%). Obser-
vation was successful in 16 out of 20 
occult pneumothoraxes (80%) exposed 
to positive pressure ventilation within 72 
hours of admission. (9) 
Case report 2
Is expectant intubation and 
mechanical ventilation of 
an infant with a congenital 
heart defect that was start-
ed on a prostaglandin infu-
sion just before transfer to 
the ICU safe? 
This was an eight hour old female infant, 
delivered after the second uneventful 
pregnancy of her 28-year old mother, 
birth weight 3560 grams, length 51 cm, 
head circumference 34 cm, 38 weeks 
of gestation, Apgar 9 and 10 at 1 and 5 
minutes consecutively, who developed 
cyanosis and was suspected to have 
duct dependent congenital heart dis-
ease (CHD). A phone call from the doc-
tor from the referral hospital informed 
the pediatric intensivists in the admit-
Figure 5. Chest  x-ray after instillation of artificial surfactant.
Figure 6. Chest x-ray of the infant on prostaglandin E1 infusion after admission 
to the intensive care unit.
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ting hospital, that the hyperoxic test with 
100% oxygen was positive for cyanotic 
CHD. A loud holosystolic murmur with 
accentuated third tone on ausculta-
tion of the heart was heard. Preductal 
oxygen saturation did not reach higher 
than 92%, and the baby had visible cen-
tral cyanosis. Otherwise she looked well 
with a normal breathing pattern. Her 
chest radiograph showed an enlarged 
heart and good transparency of the 
lungs (figure 6). Safe transportation with 
a pediatric intensivists and registered 
nurse was requested. Transportation 
by helicopter was organized to transfer 
the cyanotic baby as soon as possible 
to the Pediatric and Neonatal ICU. The 
referral doctor was encouraged by the 
intensivists to start therapy with Pros-
taglandin E1, PgE1, if available in their 
hospital, and also to be aware of the 
possible side effects of PgE1, espe-
cially of apnoeic spells. 
On the arrival of the transport team, the 
baby was lying on the resuscitation bed; 
she was eupnoic, cyanotic despite oxy-
gen through nasal prongs. No PgE1 had 
been received so far, because they did 
not have PgE1 stored in their pharmacy. 
As ductus dependent CHD was very 
likely, the transport doctor decided to 
start with PgE1 infusion and transferred 
the baby without intubation or artificial 
ventilation despite helicopter transpor-
tation. Her vital signs were stable after 
the infusion of PgE1 was started. The 
transport doctor decided to transfer the 
baby to ICU in a transport incubator 
on spontaneous breathing with opti-
mal oxygen saturation between 80 and 
90% with oxygen delivery through nasal 
prongs. The helicopter transfer went 
smoothly. As the helicopter took off an 
apnoeic spell with oxygen desatura-
tion occurred. Tactile stimulation did not 
improve her condition and the necessity 
for intubation forced the helicopter to 
land on the helipad. The pilot switched 
off the engine to stop the helicopter 
vibrations and to allow doctors to man-
age intubation and artificial ventilation. 
After the intubation and connection of 
the baby to the transport ventilator no 
further problems occurred during and 
after landing at the hospital. 
After echocardiography was done in the 
ICU by an experienced pediatric cardi-
ologist, a dysplastic tricuspid valve with 
severe regurgitation and pressure gra-
dient of at least 35 mmHg was found, 
as well as an atrial septal defect (ASD) 
secundum with right to left shunt. Mild 
dilation of the right ventricle was also 
observed. Nitric oxide was added to the 
therapy together with on-going PgE1 
infusion according to recommenda-
tions for this type of CHD. (10) In the fol-
lowing days, she was gradually weaned 
from PgE1 and nitric oxide, and was 
extubated and transferred to the pediat-
ric cardiology ward on day 8. 
Discussion of Case 2
What is the occurrence of apnoeic 
spells after PgE1 infusion and should 
Figure 8. Chest x-ray of the infant after cannulation and extra corporal mem-
brane oxygenation started.
Figure 7. Chest x-ray of the infant who needed extra corporal membrane oxy-
genation support before transport.
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the infant be intubated when helicopter 
transportation is arranged? Accord-
ing to the data, apnoeic spells occur 
in more than 10% of infants on PgE1 
infusion and is higher if a dose higher 
than 15 nanogram/kg/minute is used 
in the first hour in neonates with a body 
weight of less than 2 kg. (11)
Recent studies have shown that trans-
port of nonintubated infants who are on 
PgE1 infusion is safe and those who 
are electively intubated before trans-
portation undergo more complications 
than those who are not. (12-15) Accord-
ing to the latest recommendation of 
the Slovenian task group for the safe 
transportation of infants with ductus 
dependent CHD on PgE1 infusion, 
relative indications for intubation and 
mechanical ventilation are: diseases 
which require intubation and artificial 
ventilation, severe hypoxemia, hypoten-
sion, metabolic acidosis or cardiorespi-
ratory failure, apnoea after initiation of 
PgE1 infusion which lasts despite tac-
tile stimulation or short mask ventilation, 
some special modes of transportation 
like helicopter, long road transportation 
and bad weather reports.
They suggested that at least 30 min-
utes after the initiation of PgE1 infu-
sion the baby should be monitored 
for side effects and apnoea, and only 
afterwards should a nonintubated and 
nonventilated infant begin with transfer 
back to the admitting hospital. (15)
This case is interesting because it shows 
that if the doctor had followed the rec-
ommendations for transportation of 
infants on PgE1 infusion the likelihood 
of apnoea during take-off would have 
diminished and it would have probably 
occurred when the helicopter was still 
on the ground. 
Case report 3
How safe is expectant extra-
corporeal membrane oxy-
genation (ECMO) treatment 
in infants who are ECMO 
candidates?
This case is a one month and 25 day 
old infant girl who had a prenatally con-
firmed congenital heart defect. She was 
born vaginally, weighing 3080g and 
50 cm long When she was 1 month 
old, a surgical correction of the hypo-
plastic aortic arch and coarctation of 
aorta, ligation of patent ductus arterio-
sus (PDA) and bandage of pulmonary 
artery due to ventricular sepal defect 
(VSD) and ASD was performed. Her 
postoperative course was uneventful 
and she was transferred to the ward 
on day eight with edemid 2 mg and 
aldactone 3 mg administered once per 
day. She was on a milk formula without 
fat, Basic F formula with medium-chain 
triglycerides (MCTs) oil given orally 
1-1.5 ml/ with each meal. Nineteen days 
after the operation she was discharged 
home on the same antidiuretic therapy 
as mentioned above in good clinical 
condition and was stable. One month 
after the operation she was examined 
during her regular appointment by a 
pediatric cardiovascular surgeon. He 
found her in excellent condition and felt 
no need for further antidiuretic therapy 
or restriction of fluids. 
Twelve days later she was admitted 
by an emergency doctor to the pediat-
ric intensive care unit of the University 
Medical Centre Maribor because of res-
piratory distress, feeding difficulties and 
hypothermia. Her oxygen saturation on 
air was 80%, she was tachycardic with 
172 beats/ minute, respiratory rate 52/ 
minute and the noninvasively meas-
ured blood pressure in the right leg 
was 83/59 mmHg. A grossly enlarged 
heart was seen on the chest radiograph 
(figure 7). Echocardiography revealed 
an ejection fraction of only 26%. She 
was put on inotropes and later on vaso-
pressors (norepinephrine, dobutamine 
and dopamine) and because respira-
tory failure ensued, she was trachealy 
intubated and placed on mechani-
cal ventilation. Afterward she devel-
oped severe sudden bradycardia and 
required complete resuscitation with 
epinephrine given three times. A trans-
port team from the University Medical 
Centre Ljubljana was asked to transfer 
the girl by helicopter most probably for 
extracorporeal membrane oxygenation, 
ECMO, to support her failed myocar-
dium, of unknown cause. Prior to trans-
fer her C-reactive protein was 4 mg/ml, 
procalcitonin 0,042 ng/ml, leukocytes 
17,2 x 109/L, erythrocytes 3,7 x 109/L, 
hemoglobin 106 g/L and hematocrit 
0,33, urea 2,9 mmol/L, creatinine 30 
micromol/L, pH 7.32, base excess, BE 
-9.7, pCO2 3,75 kPa.
On admission she was sedated and 
mechanically ventilated with FiO2 1.0; 
her oxygen saturation was 90%. Her 
pupils were reactive to light. She was 
supported with norepinephrine, dop-
amine and dobutamine, her blood pres-
sure was 66/48 mm Hg, and she had a 
heart rate of 187 beats/minute. Her skin 
was cold, dry and pale. Both lungs were 
symmetrically and equally ventilated 
with normal breath sounds. A loud, sys-
tolic murmur was heard in the whole 
precordium. Capillary refilling time was 
prolonged with weak femoral pulses. 
The abdomen was soft with audible 
intense peristalsis.
Laboratory tests on admission were 
as follows: C-reactive protein 14 mg/
ml, leukocytes 14.0 x 109/L, erythro-
cytes 3.17 x 109/L, hemoglobin 89 g/L, 
hematocrit 0.27, platelets 316 x 109/L. 
glucose 8.4 mmol/L, K 4.9 mmol/L, 
Na 148 mmol/L, Cl 102 mmol/L, Ca 
1.64 mmol/L, P 2.81 mmol/L, Mg 1.02 
mmol/L, urea 7,2 mmol/L, creatinine 86 
μmol/L, protein 40 g/L, albumin 25 g/L, 
troponin 1 ng/ml, urea 21.2 mmol/L, 
lactate 19.4 mmol/L. Blood gases: pH 
7.56, pCO2 2.6, pO2 12.0, HCO3 16.9, 
cel. CO2 17.5, BE -3.9. 
Her cardiocirculatory condition deterio-
rated rapidly, so she was put on veno-
arterial extracorporeal membrane oxy-
genation support (V-A ECMO) for seven 
days (figure 8). During and just before 
ECMO connection she was resuscitat-
ed five times. Her cardiocirculatory con-
dition under ECMO support improved. 
She developed acute renal failure and 
was on peritoneal dialysis for twelve 
days. Because of resuscitation, she 
went into induced hypothermia for five 
days, with a core temperature between 
33 and 34 0C. Neurologically, she fully 
recovered during her stay in our ICU.
On day 20 she was transferred to the 
ward but 10 hours later was readmitted 
to the ICU because of sudden dete-
rioration. This time recoarctation of the 
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aorta was confirmed, catheterization 
with balloon dilation of the narrowed 
aorta transiently relieved her symp-
toms, finally she was re-operated upon 
and a plastic aortic repair with pericar-
dial patch was inserted.
Discussion of Case 3
This case is interesting because some 
infants might need ECMO support 
while waiting for transfer to a tertiary 
Neonatal and Pediatric ICU with ava-
ilable ECMO support and the issue is 
whether or not to transport such criti-
cally ill infants. In centres with deve-
loped, so called mobile ECMO, they 
simply reach a baby, connect him/her 
to the ECMO and safely transport him/
her back to the ICU. Not all units have 
mobile ECMO teams available and 
they have to make decisions based 
on their own experience of whether 
such an infant is transportable or not. 
It should firstly be noted that in expe-
rienced teams, transported and non-
transported ECMO patients have the 
same chance of survival. (16) Even 
patients with cardiac dysfunction can 
be safely transported by ECMO teams. 
(17) Wilson BJ et al. warn of risk-laden 
mortality that should not replace early 
referral to an ECMO centre despite 
acceptable survival. (18) Mobile ECMO 
teams were able to modify their criteria 
for selecting infants for long-distance 
transfer which were more rigorous. 
(19) Because mobile ECMO is very 
expensive, early referral of critically 
ill infants before all modern technical 
and medical therapies are exhausted 
is encouraged in our unit. (20,21) In 
our case, the decision to transport the 
critically ill infant was not questionable, 
at any moment, due to cardiac failure. 
It also showed that short, even repe-
ated, resuscitation had no impact on 
the neurological outcome of the girl. 
Even renal failure was not prognostic 
in her case, although some authors 
have found that renal failure is usually 
a fatal complication of ECMO. (19) 
Perreault T., in his editorial, challenges 
clinicians about the use of ECMO and 
invites them to consider all therapies: 
high frequency ventilation, nitric oxide 
and ECMO, in each centre, in order to 
ensure the safety of the patient, not 
only in terms of survival, but also of 
outcome. (22) Our experience, based 
on 20-years of ECMO use, support the 
continuation of the ECMO program, 
but earlier referral is better than later 
and lower criteria certainly are better 
for the outcome than higher. (20)
Conclusions
Regionalized tertiary intensive care 
units together with dedicated neonatal 
transport teams improve the outco-
mes of critically ill infants. Transport 
teams will always be faced with some 
unexpected events which do or do not 
become adverse. Our well-trained tran-
sport team, which has worked together 
for more than 30 years, incorporates 
strategies for risk reduction in its every-
day work. However, individual decisi-
ons have been made based on indivi-
dual perceptions of the clinical situation 
and we have hereby presented three 
such cases.
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